Clinical Trial Update: An Efficacy and Safety Study of SRM003 in the Treatment of Subjects Undergoing Creation of an Arteriovenous Fistula to Facilitate Hemodialysis Access [Phase 2]

View source ↗

Summary

Phase 2 trial update on SRM003 for patients undergoing creation of an arteriovenous fistula for hemodialysis access; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arteriovenous Fistula Formation For Hemodialysis Access

Drugs mentioned

• SRM003

Snippet

Sponsor: Shire | Conditions: Arteriovenous Fistula | Phase 2 | Status: COMPLETED | Results posted: 2015-12-24